Evans, Teresa M <br/><br/>
Moderate modulation of disease in the G93A model of ALS by the compound 2-(2-hydroxyphenyl)-benzoxazole (HBX).  [electronic resource] 

 -  Neuroscience letters  06 2016 
 - 1-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1872-7972 
<br/><br/><label>Standard No.: </label>10.1016/j.neulet.2016.04.035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyotrophic Lateral Sclerosis--metabolism<br/>Animals<br/>Benzothiazoles--administration & dosage<br/>Body Composition--drug effects<br/>Chelating Agents--administration & dosage<br/>Copper--metabolism<br/>Cystatins--metabolism<br/>Disease Models, Animal<br/>Disease Progression<br/>Female<br/>Iron--metabolism<br/>Isoprostanes--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Phenols--administration & dosage<br/>Spinal Cord--metabolism<br/>Superoxide Dismutase-1--metabolism<br/>Survival Analysis